数字病理学平台PathPresenter筹集了由AVANT BIO领导的75万美元A系列,用于功能增强和AI集成. Digital pathology platform PathPresenter raises $7.5M Series A led by AVANT BIO for feature enhancement and AI integration.

由Rajendra Singh博士创立的数字病理平台PathPresenter在AVANT BIO的领导下,在A系列A中筹集了750万美元的资金。 PathPresenter, a digital pathology platform founded by Dr. Rajendra Singh, has raised $7.5 million in Series A funding led by AVANT BIO. 投资将加强平台的特征和互操作性,目的是连接全球病理学家,提供先进的人工智能工具。 The investment will enhance the platform’s features and interoperability, aiming to connect pathologists globally and provide access to advanced AI tools. 50多个主要医院和实验室目前利用该平台,该平台力求使病理学知识民主化,并通过协作工作流程改善患者结果。 Over 50 leading hospitals and labs currently utilize the platform, which seeks to democratize pathology knowledge and improve patient outcomes through collaborative workflows.